📊 Score Breakdown
Offering Ability
20
Cash Runway
65
Float Risk
40
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
35%
🔁 Convertible Conversion
40%
• Significant convertible debt: 21% potential dilution
• Elevated convertible risk (60/100)
📉 Score Deterioration
40%
• Score rose 18 points recently (worsening)
💰 Capital Raise
15%
• Under 12 months cash (12mo)
💹 Market Data
Market Cap$80.34M
Shares Outstanding15.06M
FloatN/A
Cash$8.64M
Debt$34.68M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 61.8% shares (2025Q4 vs prior)
9 institutional holders · 55.4K shares
#1
JANE STREET GROUP, LLC
28.7K shares
#2
CITADEL ADVISORS LLC
13.3K shares
#3
Independent Advisor Alliance
11.7K shares
+ 6 more holders Sign up free to view →
📉 Short Interest
Short Interest101.4K
Days to Cover3.2
% of FloatN/A
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Dec 31, 2025
xbrl
XBRL WARRANT
Dec 31, 2021
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for NCTY
📊 NCTY FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 NCTY Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.